Kanabo Group PLC Publication of Research Note
March 23 2021 - 3:47AM
RNS Non-Regulatory
TIDMKNB
Kanabo Group PLC
23 March 2021
23 March 2021
Kanabo Group Plc
"Kanabo" or the "Company"
PUBLICATION OF RESEARCH NOTE
Kanabo Group Plc (LSE: KNB), a medical cannabis R&D Company
that focuses on the distribution of cannabis-derived products for
medical patients, and non-THC products for CBD consumers, welcomes
the publication of an analyst report by Equity Development Limited,
an experienced investment research and advisory company.
A copy of the report is available at:
https://www.equitydevelopment.co.uk/research/driven-by-safety-and-precision-1
For more information, please contact:
Kanabo Group +972 523173633
Meirav Horn, CFO
Peterhouse Capital Limited +44 (0)20 7469 0930
Eran Zucker / Lucy Williams / Allie Feuerlein
About KANABO GROUP PLC
Kanabo aims to create a new standard in the medical cannabis
industry by building an ecosystem that improves the well-being of
millions around the world by providing an alternative solution to
the smoking of medicinal cannabis flowers. With a focus on the
distribution of cannabis-derived products for medical patients, and
non-THC products for CBD consumers, Kanabo has conducted extensive
Research & Development in order to produce high-quality
cannabis extract formulas, innovative medical-grade vaporizers, and
various non-smoking consumption solutions.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAFIFSTVRIVFIL
(END) Dow Jones Newswires
March 23, 2021 04:47 ET (08:47 GMT)
Spinnaker Opportunities (LSE:SOP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Spinnaker Opportunities (LSE:SOP)
Historical Stock Chart
From Apr 2023 to Apr 2024